Respiratory and Critical Care Medicine, Regional Medical Center for the National Institute of Respiratory Disease, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Cancer Center, Zhejiang University, Hangzhou, China.
J Int Med Res. 2022 Jun;50(6):3000605221108102. doi: 10.1177/03000605221108102.
Electronic bronchoscopy is routinely used for the diagnosis and treatment of lung and bronchial disorders. However, the devices used are normally large and costly. Here, we evaluated the clinical effectiveness of a portable electronic bronchoscope produced by Zhejiang UE Medical Corp., the UE-EB.
We conducted a multi-institutional, randomized, single-blind, non-inferiority and parallel-group controlled clinical trial. Participants were randomly assigned 1:1 to the experimental group or control group. The primary indicator was the effectiveness of the device. Safety indicators were assessed from enrollment to 3 days after the operation.
The UE-EB had good consistency between groups during the procedure, and the effective rate was 100.00% in both groups. The difference value (95% confidence interval) between the two groups was 0.00% (-5.45%, 5.45%), and the lower limit was greater than -10% (negative non-inferiority margin). There was also no difference between the two groups in terms safety indicators.
The portable electronic bronchoscope described in this study showed reliable effectiveness and safety. This device is worth promoting and applying in clinical practice. ZXLB20200295 (Zhejiang Medical Products Administration, China).
电子支气管镜常用于肺部和支气管疾病的诊断和治疗。然而,所使用的设备通常体积大且价格昂贵。在此,我们评估了由浙江优亿医疗器械有限公司生产的便携式电子支气管镜 UE-EB 的临床有效性。
我们进行了一项多中心、随机、单盲、非劣效性和平行组对照临床试验。参与者按 1:1 随机分配到实验组或对照组。主要指标为器械的有效性。安全性指标从入组到操作后 3 天进行评估。
UE-EB 在手术过程中两组间具有良好的一致性,两组的有效率均为 100.00%。两组间差值(95%置信区间)为 0.00%(-5.45%,5.45%),下限大于-10%(负的非劣效性边界)。两组间的安全性指标也无差异。
本研究中描述的便携式电子支气管镜具有可靠的有效性和安全性。该设备值得在临床实践中推广和应用。ZXLB20200295(中国浙江省药品监督管理局)。